Intensive cholesterol-lowering therapy improves large artery elasticity in acute myocardial infarction patients

Heart and Vessels

Volumn 24, Issue 5, 2009, Pages 340-346

  Jia, Xinwei ^a   Wei, Meng ^b   Fu, Xianghua ^a   Gu, Xinshun ^a   Fan, Weize ^a   Zhang, Jing ^a   Xue, Ling ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Acute myocardial infarction; Ankle brachial index; Pulse wave velocity; Simvastatin therapy

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW DENSITY LIPOPROTEIN; NITRATE; SIMVASTATIN;

ACUTE HEART INFARCTION; AGED; ANKLE BRACHIAL INDEX; ARTERY TONE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ELASTICITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE;

ADMINISTRATION, ORAL; AGED; ANKLE; ARTERIES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BRACHIAL ARTERY; CHOLESTEROL; CHOLESTEROL, LDL; ELASTICITY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PULSATILE FLOW; SIMVASTATIN; TREATMENT OUTCOME;

EID: 70349638461     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1132-z     Document Type: Article

References (27)

1. Nissen SE, Tuzeu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe J, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN; REVERSAL Investigators (2004) Effect of intensive compared moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 291:1071-1080
2. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, Daida H (2004) Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event; the ESTABLISH Study. Circulation 110:1061-1068
3. Smith SC, Allen J, Blair SN, Bonow RO, Brase LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Moscal L, Pastenak RC, Pearson T, Pfeffer MA, Taubert KA; AHA/ACC; National Heart, Lung and Blood institute (2006) AHA/ACC guideline for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung and Blood Institute. J Am Coll Cardiol 47:2130-2399
4. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau J, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndrome. N Engl J Med 350:1495-1504
5. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK;Treating to New Targets (TNT) Investigators (2005) Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352:1425-1435
6. Schwartz GG, Olsson AG, Ezikowitz MD, Ganz P, Oliver MF, Waters D, Zeither A, Chaitman BR, Leslie S, Stern T (2001) The Myocardial Ischemia Reduction with Aggressive Cholesterol-lowering (MIRACL) Study Investigators: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndrome: The MIRACL study. JAMA 285:1711-1718
7. Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J (2005) Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention After myocardial infarction: The IDEAL study: a randomized controlled trial. JAMA 294:2437-2445
8. Heart Protection Study Collaborative Group (2002) MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360:7-22
9. Grundy SM, Cleeman JI Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ, for the Coordinating Committee of the National Cholesterol Education Program endorsed by the National Heart, Lung, and Blood Institute, American College of cardiology Foundation, and American Heart Association (2004) Implications of recent clinical trials for the National Cholesterol Education Program adult treatment panel III guidelines. Circulation 110:227-239
10. Shinohara K, Shoji T, Kimoto E, Yokoyama H, Fujiwara S, Hatsuda S, Maeno T, Shoji T, Fukumoto S, Emoto M, Koyama H, Nishizawa Y (2005) Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus. J Atheroscler Thromb 12:205-210
11. Raison J, Rudnichi A, Safar ME (2002) Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: A preliminary study. J Hum Hypertens 6:705-710
12. Kubota N, Kasai T, Miyauchi K, Njaman W, Kajimoto K, Akimoto Y, Kojima T, Yokoyama K, Kurata T, Daida H (2007) Therapy with statins and aspirin enhances long-term outcome of percutaneous coronary intervention. Heart Vessels 23:35-39
13. Takagi A, Tsurumi Y, Ishizuka N, Omori H, Arai K, Hagiwara N, Kasanuki H (2006) Single administration of cerivastatin, an HMGCOA reductase inhibitor, improve the coronary flow velocity reserve: A transthoracic Doppler echocardiography study. Heart Vessels 21:298-301
14. Matsuo T, Iwade K, Hirata N, Yamashita M, Ikegami H, Tanaka N, Aosaki M, Kasanuki H (2005) Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia. Heart Vessels 20:8-12
15. Bonetti PO, Lerman LO, Napoli C, Lerman A (2003) Statin effects beyond lipid lowering-are they clinically relevant? Eur Heart J 24:225-248
16. Koutouzis M, Nomikos A, Nikolidakis S, Tzavara V, Andrikopoulos V, Nikolaou N, Barbatis C, Kyriakides ZS (2007) Statin treated patients have reduced intraplaque angiogenesis in carotid endarterectomy specimens. Atherosclerosis 192:457-463
17. Stefanadis C, Toutouzas K, Tsiamis E, Vavuranakis M, Tsioufis C, Stefanadi E, Boudoulas H (2007) Relation between local temperature and C reactive protein levels in patients with coronary artery disease: Effect of atorvastatin treatment. Atherosclerosis 192:396-400
18. Kim JS, Kang TS, Kim TB, Seo HS, Park S, Kim C, Ko YG, Choi D, Jang Y, Chung N (2007) Significant association of C-reactive protein with arterial stiffness in treated non-diabetic hypertension patients. Atherosclerosis 192:401-406
19. Kameyama H, Takeda K, Kusaba T, Narumiya H, Tanda S, Kuwahara N, Yamada K, Tamagaki K, Okigaki M, Hatta T, Sasaki S (2005) Augmentation of pulse wave velocity precedes vascular structural changes of the aorta in rats treated with N(omega)-nitro-L-arginine methyl ester. Hypertens Res 28:439-445
20. Jensen LO, Thayssen P, Pedersen KE, Stender S, Haghfelt T (2004) Regression of coronary atherosclerosis by simvastatin: A serial intravascular ultrasound study. Circulation 110:265-270
21. Lima JA, Desai MY, Steen H, Warren WP, Gautam S, Lai S (2004) Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 110:2336-2341
22. Zebekakis PE, Nawrot T, Thijs L, Balkestein EJ, van der Heijden-Spek J, Van Bortel LM, Struijker-Boudier HA, Safar ME, Staessen JA (2005) Obesity is associated with increased arterial stiffness from adolescence until old age. J Hypertens 23:1839-1846
23. Kim JW, Park CG, Hong SJ, Park SM, Rha SW, Seo HS, Oh DJ, Rho YM (2005) Acute and chronic effects of cigarette smoking on arterial stiffness. Blood Press 14:80-85
24. Nurnberger J, Dammer S, Opazo Saez A, Philipp T, Schafers RF (2003) Diastolic blood pressure is an important determinant of augmentation index and pulse wave velocity in young, healthy males. J Hum Hypertens 17:153-158
25. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG (2002) Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function? Circulation 106:2085-2090
26. Asmar R (2001) Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: Clinical implications. Am J Cardiovasc Drugs 1:387-397
27. Anan F, Takahashi N, Ooie T, Yufu K, Hara M, Nakagawa M, Yonemochi H, Ssikawa T, Yoshimatsu H (2005) Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension. Eur J Clin Pharmacol 61:353-359